Mr. Bart W Hodgins, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 802 Fairview Rd, Suite 1200, Asherville, NC 28803 Phone: 828-298-5435 Fax: 828-298-5822 |
News Archive
Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind the resistance to HER2- or PI3K-targeted therapies, and a treatment strategy that may overcome treatment resistance.
Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today reported positive preclinical data for its lead therapeutic MANF in neuroprotection 6-hydroxydopamine (6-OHDA) rat models of Parkinson's disease.
Carbonation, an essential component of popular soft drinks, alters the brain's perception of sweetness and makes it difficult for the brain to determine the difference between sugar and artificial sweeteners, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association.
Fetal brains use a special amplifier in order to transmit signals, according to research published in the journal eLife by George Washington University's (GW) Matthew Colonnese, Ph.D. and Yasunobu Murata, Ph.D. Early neural connections are sparse, weak, and unreliable.
Researchers studying a new medication for neuropathic pain have reported intriguing findings about placebo response versus drug response from a Phase 2a proof-of-concept study. They presented their findings in a poster session at the 2011 International Conference on Accelerating the Development of Enhanced Pain Treatments.
› Verified 3 days ago